Four‑Gene Blood Test Spots HBV Cirrhosis Early

People with long‑term hepatitis B often see their livers become scarred, a condition called cirrhosis. This shift happens because the immune system goes haywire and the chemical messengers that guide inflammation change. Doctors still lack a simple blood test that can spot this danger early.

Researchers dug into a public collection of gene‑activity data from blood cells of patients with chronic hepatitis B and those already showing cirrhosis. They looked for genes that behaved differently between the two groups. After filtering through many candidates, they settled on four immune‑related genes: CXCR1, IL11RA, IL13RA2 and CD19. These genes sit on pathways linked to inflammation, scar formation and B‑cell activity.

Using a statistical method that picks the most useful genes and a standard logistic model, the team built a risk calculator. When they tested it, the tool reached an AUC of about 0.94, meaning it correctly separates patients with and without cirrhosis most of the time. At a cut‑off point, it caught roughly 89% of true cases while correctly labeling about 84% of healthy ones as negative. Leave‑one‑out cross‑validation confirmed the numbers stayed stable.

The four‑gene blood profile offers a non‑invasive way to gauge who is at high risk for HBV‑driven liver scarring. It could be used to guide when to start treatment or to monitor immune changes over time. More large‑scale studies are needed to prove the approach works across different groups and to uncover why these genes behave the way they do.